Daniele Marinelli

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Daniele Marinelli
Apr 14, 2025, 07:18 | Insight
Roberto Ferrara: Time to tailor chemo-IO in early stage NSCLC
Roberto Ferrara, Medical Oncologist,Researcher in Thoracic Oncology and Molecular Immunology at Vita-Salute San Raffaele University,…
Mar 11, 2025, 06:38 | Blog
Filippo Gallina: Establishing survival benchmarks in the era of peri-operative immunotherapy
Filippo Gallina, Thoracic Surgeon at IRCCS National Cancer Institute of Rome, shared a paper he…
Jan 16, 2025, 22:20 | Blog
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
Svetlana Nikic shared on LinkedIn: "New data just out from TRACERx in Nature Medicine showing that…
Jan 15, 2025, 04:29 | Blog
Charles Swanton: Ultrasensitive ctDNA detection for early-stage NSCLC stratification
Charles Swanton , Professor of Cancer Medicine at the University College London Cancer Institute, shared…
Jan 13, 2025, 17:35 | Insight
UCL and Francis Crick Institute Test Uses Tumor DNA to Predict Lung Cancer Outcomes
Scientists from the Francis Crick Institute, UCL, UCLH, and Personalis have developed a promising new…
Nov 3, 2024, 16:27 | Insight
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Alessandro Di Federico, Medical Oncologist and Ph.D. student at the University of Bologna, shared a…
Aug 18, 2024, 06:12 | Blog
Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC
Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…
Jul 14, 2024, 06:26 | Insight
Daniele Marinelli: NRF2-driven transcription in NSCLC
Daniele Marinelli, PhD student at the Sapienza University of Rome, shared a post on X…
All: 8 Posts: 1 - 100
Special Coverage